Enterprise List

Shenzhen Boya Gene Technology Co., Ltd. is a biotechnology startup focused on the research and clinical translation of gene therapy drugs, with a focus on chronic diseases and functional degenerative diseases that seriously affect the health of a large number of elderly people. Our gene drug uses adenovirus associated virus (AAV) as a delivery technology.

Shengbao Biotechnology Co., Ltd. was established in 2023 and is headquartered in Shenzhen, China. The company is committed to developing innovative live bacterial drugs, utilizing gene circuits and precise regulation of gene and payload expression to meet the treatment needs of various types of diseases.

Shenzhen Pruqi Biotechnology Co., Ltd. (referred to as "Pruqi Biotechnology") was established in 2024 and is an innovative biotechnology enterprise focusing on the field of pet health. Its headquarters is located in Guangming District, Shenzhen. Our mission is to empower pet health through technological innovation, and we are committed to becoming a leader in the field of pet bioproducts.

Zhongke Xinfei is committed to innovative phage synthesis biology therapies to solve the increasingly severe problem of drug-resistant bacterial infections in clinical practice and improve the survival rate of patients with multidrug-resistant bacterial infections. Zhongke Xinfei has established multiple leading technology platforms, including synthetic biology phage modification platform and IBT fusion technology phage screening platform, which can quickly develop artificial phage products with stronger bactericidal effect, safer, and easier standardized preparation.

Anhe (Shenzhen) Health Technology Co., Ltd. was founded on January 15, 2016, with its headquarters located at 403A, 4th floor, Building C, Guanghui Technology Building, Minqing Road, Fukang Community, Longhua Street, Longhua District, Shenzhen.